T.GUD
|
http://www.globenewswire.com/news-release/2019/07/08/1879781/0/en/Knight...
|
T.GUD
|
Via: https://globenewswire.com/news-release/2018/11/26/1656949/0/en...
|
T.DFN
|
NAV (as of Oct. 15, 2018): $17.10 As expected, Common Shares will continue...
|
T.DF
|
NAV (as of Oct. 15, 2018): $13.95 Long ways to go until Common Shares...
|
T.DFN
|
NAV (as of Sept. 28, 2018) = $7.90 Share Price (as of Oct. 10, 2018...
|
T.GUD
|
More here: https://www.nasdaq.com/press-release/knight-therapeutics-and...
|
T.CXR.R
|
There is news: http://www.businessinsider.com/concordia-international...
|
T.CXR.R
|
http://www.streetinsider.com/Hedge+Funds/Concordia+Healthcare+%28CXRX%29+CEO...
|
T.CXR.R
|
Press release out for the acquisition of the generic products: OAKVILLE, ON...
|
T.CXR.R
|
Cash should also be subtracted to get to final EV. EV = market value of...
|
T.DF
|
Agreed. I wonder if buyers have realized there won't be a dividend for...
|
T.DF
|
Sorry I meant Jan. 15, 2016 not 2015.
|
T.DFN
|
$16.39 as of Jan. 15, 2016 Still well above the $15 threshold. http://www...
|
T.DF
|
$13.46 as of Jan. 15, 2015 http://www.quadravest.com/#!df-fund-features...
|
T.DFN
|
The NAV is not an issue for DFN at this point. I'm guessing the early...
|
T.DFN
|
Unsurprisingly, DFN continues to pay a dividend: http://www.einnews.com/pr...
|
T.DFN
|
Agreed, this is way oversold. Buyers who got in at $7.10 today may have even...
|
T.DF
|
NAV Update as of Dec. 31, 2015: http://www.quadravest.com/#!df-fund-features...
|
T.DF
|
Paying a premium on NAV with no dividend backing it at the moment is not what...
|
T.DF
|
No dividend is being paid to common shares: http://www.streetinsider.com/dr...
|